Julie Kobie
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 16
- Colorectal Cancer Treatments and Studies 5
- Pancreatic and Hepatic Oncology Research 4
-
- Gastric Cancer Management and Outcomes 9
- Lung Cancer Treatments and Mutations 9
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 8
- Otorhinolaryngology top 10%
- Gastroenterology top 10%
-
- Esophageal Cancer Research and Treatment 6
-
- Ovarian cancer diagnosis and treatment 3
- Co-authors
- Răzvan CristescuBilal PiperdiDeepti Aurora-GargMark AyersJared LuncefordRoy S. HerbstM. Catherine PietanzaByoung Chul Cho
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesSouth KoreaItaly
In The Last Decade
Julie Kobie
27 papers receiving 960 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Oncology 789
- Pulmonary and Respiratory Medicine 647
- Cancer Research 176
- Otorhinolaryngology 47
- Gastroenterology 47
Countries citing papers authored by Julie Kobie
This map shows the geographic impact of Julie Kobie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Kobie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Kobie more than expected).
Fields of papers citing papers by Julie Kobie
This network shows the impact of papers produced by Julie Kobie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Kobie. The network helps show where Julie Kobie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie Kobie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 40 | |
| 4 | 2023 | 19 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 55 | |
| 7 | 2021 | 40 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 42 | |
| 10 | Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLCbreakdown → | 2021 | 201 |
| 11 | 2020 | 11 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 22 | |
| 14 | 2019 | 79 | |
| 15 | 2019 | 66 | |
| 16 | 2019 | 12 | |
| 17 | 2019 | 74 | |
| 18 | 2018 | 7 | |
| 19 | 2018 | 51 | |
| 20 | 2016 | 1 |
About Julie Kobie
Julie Kobie is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 967 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), Gastric Cancer Management and Outcomes (9 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer Genomics and Diagnostics (8 papers), Esophageal Cancer Research and Treatment (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Oncology (789 citations), Pulmonary and Respiratory Medicine (647 citations) and Cancer Research (176 citations). Julie Kobie has collaborated with scholars based in United States, South Korea and Italy. Frequent co-authors include Răzvan Cristescu, Bilal Piperdi, Deepti Aurora-Garg, Mark Ayers, Jared Lunceford, Roy S. Herbst, M. Catherine Pietanza, Byoung Chul Cho, Andrey Loboda and Edward B. Garon. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.